BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 09, 2009
 |  BioCentury  |  Strategy

Vertex chronicles

Vertex chronicles

Vertex(NASDAQ:VRTX), founded in 1989, has gained more than 670% since going public in 1991. The stock ended 2008 up 31% vs. a 20% drop in the BioCentury 100 index. Below are selected events tracked against Vertex's weekly stock price since 1991. A. 7/24/91 - Vertex raises $28.8M in an IPO

B. April 1993 - Partners with Kissei(Tokyo:4547) to develop HIV protease inhibitors in the Far East

C. September 1993 - Partners with Roussel Uclaf, now part of sanofi-aventis (Euronext: SAN; NYSE:SNY), to develop orally active drugs to treat inflammatory diseases

D. December 1993 - Partners to develop orally active protease inhibitors to treat HIV and AIDS with Wellcome, now part of GlaxoSmithKline(LSE:GSK; NYSE:GSK)E. 1/25/94 - Raises $62.1M in a follow-onF. 11/10/94 - Raises $15M in a private placementG. 8/9/96 - Raises $82.8M in a follow-onH. 3/7/97 - Raises...

Read the full 678 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >